Skip to Content
Merck

Pathology of inherited manganese transporter deficiency.

Annals of neurology (2014-03-07)
Mirna Lechpammer, Michael S Clegg, Zukhrofi Muzar, Philip A Huebner, Lee-Way Jin, Sidney M Gospe
ABSTRACT

We followed a patient with manganese transporter deficiency due to homozygous SLC30A10 mutations from age 14 years until his death at age 38 years and present the first postmortem findings of this disorder. The basal ganglia showed neuronal loss, rhodanine-positive deposits, astrocytosis, myelin loss, and spongiosis. SLC30A10 protein was reduced in residual basal ganglia neurons. Depigmentation of the substantia nigra and other brainstem nuclei was present. Manganese content of basal ganglia and liver was increased 16-fold and 9-fold, respectively. Our study provides a pathological foundation for further investigation of central nervous system toxicity secondary to deregulation of manganese metabolism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Manganese, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
Manganese, chips, thickness <2.0 mm, 99%
Sigma-Aldrich
Manganese, powder, ≥99.9% trace metals basis